Literature DB >> 16684540

Platelet-activating factor-induced NF-kappaB activation enhances VEGF expression through a decrease in p53 activity.

Hyun-Mi Ko1, Hae Hyun Jung, Kook Heon Seo, Yeong-Rim Kang, Han-A Kim, Sung Jun Park, Hern-Ku Lee, Suhn-Young Im.   

Abstract

We investigated the role of p53 in nuclear factor (NF)-kappaB dependent, platelet-activating factor (PAF)-induced vascular endothelial growth factor (VEGF) expression. Transfected NF-kappaB subunits in ECV304 cells increased the tumor necrosis factor-alpha promoter activity, which was completely inhibited by p53. Transfected p53 increased p53RE promoter activity, which was completely inhibited by NF-kappaB subunits, indicating that cross-regulation occurs between NF-kappaB and p53. PAF-induced increase in VEGF expression was correlated with decreased p53 activity. These data suggest that NF-kappaB-dependency of the PAF-induced increase in VEGF expression is due to decreased p53 activity, which is reciprocally regulated by increased NF-kappaB activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16684540     DOI: 10.1016/j.febslet.2006.04.042

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

Review 1.  Angiogenesis in diabetes and obesity.

Authors:  Rui Cheng; Jian-xing Ma
Journal:  Rev Endocr Metab Disord       Date:  2015-03       Impact factor: 6.514

2.  Ds-echinoside A, a new triterpene glycoside derived from sea cucumber, exhibits antimetastatic activity via the inhibition of NF-κB-dependent MMP-9 and VEGF expressions.

Authors:  Qin Zhao; Zhi-dong Liu; Yong Xue; Jing-feng Wang; Hui Li; Qing-juan Tang; Yu-ming Wang; Ping Dong; Chang-hu Xue
Journal:  J Zhejiang Univ Sci B       Date:  2011-07       Impact factor: 3.066

3.  PAF receptor antagonist Ginkgolide B inhibits tumourigenesis and angiogenesis in colitis-associated cancer.

Authors:  Lei Sun; Zhen He; Jia Ke; Senmao Li; Xianrui Wu; Lei Lian; Xiaowen He; Xiaosheng He; Jiancong Hu; Yifeng Zou; Xiaojian Wu; Ping Lan
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

4.  Ginkgolides and bilobalide protect BV2 microglia cells against OGD/reoxygenation injury by inhibiting TLR2/4 signaling pathways.

Authors:  Jian-Ming Zhou; Sha-Sha Gu; Wang Hong Mei; Jun Zhou; Zhen Zhong Wang; Wei Xiao
Journal:  Cell Stress Chaperones       Date:  2016-08-25       Impact factor: 3.667

5.  Multi-gene targeted antiangiogenic therapies for experimental corneal neovascularization.

Authors:  Peng Chen; Hongmei Yin; Yao Wang; Jing Mi; Wenxiao He; Lixin Xie; Yiqiang Wang
Journal:  Mol Vis       Date:  2010-02-27       Impact factor: 2.367

6.  Platelet-activating factor receptor (PAF-R)-dependent pathways control tumour growth and tumour response to chemotherapy.

Authors:  Soraya I de Oliveira; Luciana N S Andrade; Ana C Onuchic; Sueli Nonogaki; Patrícia D Fernandes; Mônica C Pinheiro; Ciro B S Rohde; Roger Chammas; Sonia Jancar
Journal:  BMC Cancer       Date:  2010-05-13       Impact factor: 4.430

7.  Platelet-activating factor-induced NF-kappaB activation and IL-8 production in intestinal epithelial cells are Bcl10-dependent.

Authors:  Alip Borthakur; Sumit Bhattacharyya; Waddah A Alrefai; Joanne K Tobacman; Krishnamurthy Ramaswamy; Pradeep K Dudeja
Journal:  Inflamm Bowel Dis       Date:  2010-04       Impact factor: 5.325

8.  Inhibition of VEGF expression and corneal neovascularization by shRNA targeting HIF-1α in a mouse model of closed eye contact lens wear.

Authors:  Peng Chen; Hongmei Yin; Ye Wang; Yao Wang; Lixin Xie
Journal:  Mol Vis       Date:  2012-04-06       Impact factor: 2.367

9.  Elevated Platelet to Lymphocyte Ratio Is Associated with Poor Survival Outcomes in Patients with Colorectal Cancer.

Authors:  Xiaobin Gu; Xian-Shu Gao; Shangbin Qin; Xiaoying Li; Xin Qi; Mingwei Ma; Hao Yu; Shaoqian Sun; Dong Zhou; Wen Wang; Wei Xiong
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

10.  Oligodendrocyte-specific ATF4 inactivation does not influence the development of EAE.

Authors:  Yuan Yue; Milos Stanojlovic; Yifeng Lin; Gerard Karsenty; Wensheng Lin
Journal:  J Neuroinflammation       Date:  2019-02-01       Impact factor: 8.322

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.